Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fibrosis Versus Metabolic Risk in MASLD: Age-Adjusted Associations With PREVENT Cardiovascular Risk

NCT07791589 is registered in ClinicalTrials.gov with Özgür Bahadır as lead sponsor.

NCT NCT07791589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07791589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fibrosis Versus Metabolic Risk in MASLD: Age-Adjusted Associations With PREVENT Cardiovascular Risk
Lead sponsor
Özgür Bahadır
Phase
Observational
Overall status
Completed
Start date
June 1, 2026
Completion date
July 1, 2026
Enrollment
271 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated steatotic liver disease